ADVANCED LUNG CARCINOMA
Clinical trials for ADVANCED LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets tough cancers: early trial underway
Disease control OngoingThis study tests an experimental oral drug called silevertinib (BDTX-1535) in about 200 adults with advanced non-small cell lung cancer or glioblastoma, a type of brain cancer. The drug is designed to block specific EGFR mutations that help these cancers grow. The trial has two p…
Matched conditions: ADVANCED LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo attack on lung cancer: targeted drug plus surgery or radiation
Disease control OngoingThis early-phase trial is testing whether adding local treatments like surgery or radiation to the targeted drug brigatinib can help control advanced ALK-positive non-small cell lung cancer. About 35 people who have not yet taken other targeted therapies will receive brigatinib f…
Matched conditions: ADVANCED LUNG CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New program aims to ease fear in advanced cancer patients
Symptom relief OngoingThis study tests a nurse-led program designed to help people with advanced lung or gynecologic cancer manage their fears about the future. The program is delivered through video sessions and includes coping strategies. The study will enroll 42 patients to see if the program is pr…
Matched conditions: ADVANCED LUNG CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC